FBS by Biochemical Assays – Does This Make Sense?
Julian Woelcke, Associate Director, Novartis Pharma AG, speaking at Screening Europe 2010.
Development of an AlphsScreen HTS Assay for Low Affinity Epigenetic Peptide-Protein Interactions
Tim Wigle, Postdoc, University of North Carolina, speaking at Screening Europe 2010.
Kinome Activity Profiling: A New Approach for Target Discovery and Response Prediction
Rinie van Beuningen, Vice President Business Development, PamGene International B.V., speaking at Screening Europe 2010.
Screening for Selectivity
Joost Uitdehaag, Group Leader, Schering-Plough Research Institute, speaking at Screening Europe 2010.
Real Time Screening of GIRK1/4 Channel Blockers
Kenneth Walsh, University of South Carolina, Associate Professor, speaking at Ion Channel Targets 2010.
Small Molecule Probe Discovery by High Throughput Flow Cytometry at the University of New Mexico Center for Molecular Discovery
Larry Sklar, Professor, University of New Mexico, speaking at Probe Discovery 2009
Economy in the Scale: Smaller can be better in High Content Screening
Anthony Davies, Director High Content Research Facility, Trinity College Dublin, speaking at Screening Europe 2010
Small-molecule Probes of Inward Rectifying Potassium Channels
Jerod Denton, Vanderbilt University, Assistant Professor, speaking at Ion Channel Targets 2010.
KCa3.1 Blockers as Potential New Drugs for the Prevention of Chronic Allograft Rejection and the Treatment of IBD
Heike Wulff, University of California, Davis, Associate Professor, speaking at Ion Channel Targets 2010.